首页> 中文期刊> 《实用医学影像杂志》 >磁共振成像在卵巢肿瘤定性及恶性肿瘤分期的临床应用

磁共振成像在卵巢肿瘤定性及恶性肿瘤分期的临床应用

         

摘要

目的:探讨磁共振成像(MRI)在卵巢肿瘤的诊断及卵巢癌分期方面的应用价值方法。方法选取2014年1月至2016年1月在我院就诊的卵巢肿瘤患者共计45例,所有患者均在我院接受术前MRI检测及手术治疗,手术后标本行病理学诊断。比较2种检测方法在病理结果、临床分期方面的吻合情况。结果使用κ系数法(Kappa)分析MRI检测与病理诊断、病理分期的吻合情况,McNemar检验结果为P=0.072、0.317,2种诊断方法结果差异无统计学意义,2种诊断的吻合系数κ=0.663,P<0.05;κ=0.855,P<0.05,说明2种诊断方法的吻合度较强,并且差异有统计学意义。结论 MRI在卵巢肿瘤定性以及卵巢癌术前分期中发挥重要临床价值。%Objective To explore the application value of magnetic resonance imaging (MRI) in the diagnosis and staging of ovarian cancer. Methods A total of 45 patients with ovarian cancer were selected from January 2014 to January 2016 in our hospital. All the patients received preoperative MRI examination and surgical treatment. The pathological diagnosis was performed after the operation. The anastomosis of the two kinds of detection methods in pathological results and clinical stage was compared. Results The coefficient analysis of MRI and pathological diag﹣nosis, pathological staging of anastomosis was done, McNemar′s test results were P=0.072, 0.317, two diagnosis meth ods showed no significant difference, with the two diagnostic agreement coefficient κ=0.663, P<0.05; κ=0.855, P<0.05. The anastomosis of the two diagnostic methods was stronger, and there was significant statistical significance. Conclusion MRI plays an important clinical value in the preoperative staging of ovarian cancer.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号